Clinical trials
Phase 1/2 Skin Neoplasms trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
26 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 3 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 2 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Terminated | 6 |
| Recruiting | 5 |
| Unknown status | 2 |
| Active, not recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 2 |
| 7 Hills Pharma, LLC | 1 |
| Bruce Robinson, MD | 1 |
| Dynavax Technologies Corporation | 1 |
| Exicure, Inc. | 1 |
| Hussein Tawbi | 1 |
| Incyte Corporation | 1 |
| Iovance Biotherapeutics, Inc. | 1 |
| Klus Pharma Inc. | 1 |
| Ludwig Institute for Cancer Research | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Skin Neoplasms | 26 |
| Melanoma | 16 |
| Neoplasms | 11 |
| Basal Cell Carcinoma | 5 |
| Carcinoma, Non-Small-Cell Lung | 5 |
| Lung Neoplasms | 5 |
| Ovarian Neoplasms | 4 |
| Carcinoma, Merkel Cell | 3 |
| Carcinoma, Renal Cell | 3 |
| Colorectal Neoplasms | 3 |
Trials
Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.